First Trust Advisors
AMLX icon

First Trust Advisors’s Amylyx Pharmaceuticals AMLX Stock Holding History

First Trust Advisors’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.57M Buy
+254,587
New +$3.94M ﹤0.01% 1644
2024
Q4 		– Sell
-221,626
Closed -$718K – 2557
2024
Q3 		$718K Buy
221,626
+82,529
+59% +$186K ﹤0.01% 2093
2024
Q2 		$264K Sell
139,097
-31,381
-18% -$60.8K ﹤0.01% 2223
2024
Q1 		$484K Buy
170,478
+153,098
+881% +$2M ﹤0.01% 2157
2023
Q4 		$256K Buy
+17,380
New +$266K ﹤0.01% 2260
2023
Q3 		– Sell
-54,115
Closed -$1.17M – 2348
2023
Q2 		$1.17M Buy
54,115
+26,798
+98% +$724K ﹤0.01% 1936
2023
Q1 		$801K Sell
27,317
-29,503
-52% -$1.02M ﹤0.01% 2023
2022
Q4 		$2.1M Buy
+56,820
New +$2.02M ﹤0.01% 1677

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

First Trust Advisors's AMLX Position: Q2 2026 in Review

First Trust Advisors opened a new position in Amylyx Pharmaceuticals (AMLX) in Q2 2026: 254,587 shares worth $4.57M. The stake represents ﹤0.01% of the portfolio and ranks #1644 among its holdings. This is a return to the name: First Trust Advisors previously reported a position in AMLX as recently as Q3 2024.

First Trust Advisors first reported a position in AMLX in Q4 2022 and has held it in 8 quarters since. 207 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • First Trust Advisors held 254,587 shares of Amylyx Pharmaceuticals worth $4.57M as of Q2 2026.
  • Amylyx Pharmaceuticals was a new First Trust Advisors position in Q2 2026.
  • Amylyx Pharmaceuticals made up ﹤0.01% of First Trust Advisors's portfolio in Q2 2026, its #1644 holding.
  • First Trust Advisors first reported a position in Amylyx Pharmaceuticals in Q4 2022 and has held it in 8 quarters since.
  • 207 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.